ASII:IDXPT Astra International Tbk Analysis
Data as of 2026-03-11 - not real-time
$0.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock is trading near its recent resistance level, with price hovering at the upper bound of its 52‑week range. The 20‑day simple moving average sits just above the 50‑day SMA, suggesting a modest short‑term upward bias. However, the 200‑day SMA remains higher, indicating that longer‑term momentum is still lacking. The RSI is around the midpoint, reflecting a neutral overbought/oversold condition. The MACD histogram has turned positive and the signal line is bullish, but the divergence between the MACD line and the signal line is narrow. Volume has been increasing despite the overall thin trading, which adds a slight supportive backdrop. Volatility is extremely high, with a 30‑day swing approaching three‑hundred percent, and the max drawdown has recently breached eighty percent. The fear‑and‑greed index is in the Extreme Greed zone, hinting at heightened speculative enthusiasm. Beta is modest, suggesting limited correlation with broader market moves, yet the price action remains erratic. Overall, the technical picture is mixed, with short‑term bullish cues offset by pronounced volatility and a lack of sustained trend.
On the fundamentals side, revenue has surged by well over forty percent year‑over‑year, but gross and operating margins are deeply negative, and the company is generating no earnings. Cash flow is severely constrained, with operating cash outflows and a massive free‑cash‑flow deficit, while total debt dwarfs the modest cash balance. The balance sheet weakness is reflected in a near‑zero price‑to‑sales multiple that appears cheap only because earnings are absent. Liquidity is a concern given the minuscule daily volume and a market cap that places the stock in penny‑stock territory. Consequently, the investment thesis is dominated by high risk, limited upside, and a need for a dramatic turnaround to justify any valuation.
On the fundamentals side, revenue has surged by well over forty percent year‑over‑year, but gross and operating margins are deeply negative, and the company is generating no earnings. Cash flow is severely constrained, with operating cash outflows and a massive free‑cash‑flow deficit, while total debt dwarfs the modest cash balance. The balance sheet weakness is reflected in a near‑zero price‑to‑sales multiple that appears cheap only because earnings are absent. Liquidity is a concern given the minuscule daily volume and a market cap that places the stock in penny‑stock territory. Consequently, the investment thesis is dominated by high risk, limited upside, and a need for a dramatic turnaround to justify any valuation.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bullish MACD signal but neutral overall trend
- Extreme volatility and large max drawdown
- Price at resistance with thin liquidity
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue growth
- Negative margins and cash flow
- Increasing volume but still low liquidity
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- High debt relative to cash
- No earnings and negative cash flow
- Persistent high volatility and speculative sentiment
Key Metrics & Analysis
Financial Health
Revenue Growth46.60%
Profit Margin434.90%
ROA-77.24%
Op. Cash Flow$-316774
Free Cash Flow$-5170627
Technical Analysis
TrendNeutral
RSI51.9
Support$0.00
Resistance$0.00
MA 20$0.00
MA 50$0.00
MA 200$0.00
MACDBullish
VolumeIncreasing
Fear & Greed Index76.68
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.47
Volatility288.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.